Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
selective and orally active small molecule agonist of adiponectin receptor (AdipoR)
Frigerio M
The expression of Wnt-target genes (AXIN2
12(24):2727-40
the FDA indicated that indiplon-IR was approvable and plans are to resubmit the application in 2007
TraMetinib - CAS# 871700-17-3 0201 selective and orally active smallTrametinib, also known as GSK1120212, CAS No. 871700 17 3, is a n orally bioavailable inhibitor of mitogen activated protein kinase kinase (MEK MAPK ERK kinase) with potential antineoplastic activity. Trametinib specifically binds to and inhibits MEK 1 and 2, resulting in an inhibition of growth factor mediated cell signaling and cellular proliferation in various cancers. MEK 1 and 2, dual specificity threonine tyrosine kinases often upregulated in
US$ 30.00
US$ 18.00
US$ 188.00
US$ 55.00
US$ 112.00
US$ 50.00
US$ 30.00
US$ 263.00
US$ 15.00
US$ 10.00
US$ 29.00